Catalyst Funds Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,905	Closed	-$52.8K	–	444
2025 Q1	$52.8K	Buy	+14,905	New	+$52.8K	0.01%	412
2024 Q4	–	Sell	-7,500	Closed	-$24.3K	–	349
2024 Q3	$24.3K	Hold	7,500	–	–	0.01%	1037
2024 Q2	$14.3K	Buy	+7,500	New	+$14.3K	﹤0.01%	801